Subscription for Specialized Data Driven Insight and Analytics for Pharmaceutical Markets

SUNY Upstate Medical University (SUNY Upstate) intends to purchase under its discretionary authority, pursuant to NYS Education Law §355(5)(a), the below described commodity/product or service which authorizes purchases without a formal competitive process in certain circumstances. A sealed bid will not be held. If you are interested in providing a proposal for the below described commodity/product or service, you must contact the appropriately designated Hospital contact in this advertisement within 15 business days of this Advertisement Notice. Contacting any other individuals at SUNY Upstate in connection with this advertisement may constitute a violation of New York State Finance Law. This procurement is subject to NYS Finance Law §139 j&k, AKA the Lobbying Law. Therefore, vendors are cautioned that the only permissible contact for this procurement is the individual listed below. Failure to comply with this requirement can range from no contract award to debarment from sales to any NYS Agency. Successful contractor shall be required to submit valid and current NYS Workman’s Compensation and Disability Forms. Successful contractor shall be required to complete and submit applicable documents related to Vendor Responsibility, NYS Finance Law §139 j&k, and New York State’s Tax Law Section 5-a. Commodity/Product or Service Description: A subscription to a platform that detects, casts, and measures the impacts of competitive-landscape alterations in the pharmaceutical market. The following areas: - Drug life-cycle analysis - Clinical, formulary, procurement, and inventory-control insights - Market Impacts forecasts for both brand and generic medications - Pharmacy reimbursement and coding information - Analyzations of high-impact rules, regulations, executive orders and understanding of the potential impacts on the healthcare system Anyone who can provide the above-described product(s) is invited to contact Michael Cushner at [email protected] Business enterprises awarded an identical or substantially similar procurement contract within the past five years: None